晕痣的研究进展

doi:10.35541/cjd.20230318

Abstract

Li Rui, Li Hongyang, Zhou Jia, Zhang Wei, Zeng Xuesi. Research progress in halo nevi[J]. Chinese Journal of Dermatology,2023,e20230318. doi:10.35541/cjd.20230318

References ［35］

［1］	De Giorgi V, Colombo J, Salvati L, et al. Eruptive halo nevi: a new COVID⁃19 vaccine⁃related cutaneous adverse event or a paraneoplastic phenomenon?［J］. Dermatol Ther, 2022,35（9）:e15722. doi: 10.1111/dth.15722.
［2］	Jia WX, Zhang YY, Li CR. Four⁃color halo congenital nevus［J］. J Cosmet Dermatol, 2021,20（11）:3712⁃3713. doi: 10.1111/jocd.14056.
［3］	Babu A, Bhat MR, Dandeli S, et al. Throwing light onto the core of a halo nevus: a new finding［J］. Indian J Dermatol, 2016,61（2）:238. doi: 10.4103/0019⁃5154.177801.
［4］	Hassab⁃El⁃Naby H, Rageh MA. Agminated halo nevus: a novel presentation［J］. Am J Dermatopathol, 2023,45（6）:388⁃390. doi: 10.1097/DAD.0000000000002417.
［5］	Rongioletti F, Cecchi F, Rebora A. Halo phenomenon in melanocytic nevi（Sutton′s nevi）. Does the diameter matter?［J］. J Eur Acad Dermatol Venereol, 2011,25（10）:1231⁃1232. doi: 10.1111/j.1468⁃3083.2010.03790.x.
［6］	Haynes D, Strunck JL, Said J, et al. Association between halo nevi and melanoma in adults: a multicenter retrospective case series［J］. J Am Acad Dermatol, 2021,84（4）:1164⁃1166. doi: 10.1016/j.jaad.2020.08.056.
［7］	Yamazaki E, Irimada M, Sasaki R, et al. Multiple halo nevi associated with Turner syndrome［J］. J Dermatol, 2021,48（1）:e11⁃e12. doi: 10.1111/1346⁃8138.15643.
［8］	黄新绿, 杜娟, 徐前喜, 等. 晕痣的流行病学调查、临床特征及皮肤镜表现［J］. 中国皮肤性病学杂志, 2021,35（12）:1371⁃1376.doi:10.13735/j.cjdv.1001⁃7089.202106084
［9］	Pogorzelska⁃Antkowiak A, Corneli P, Agozzino M. In vivo reflectance confocal microscopy of halo nevi［J］. Skin Res Technol, 2021,27（5）:841⁃845. doi: 10.1111/srt.13029.
［10］	Pan C, Shang J, Jiang H, et al. Transcriptome analysis reveals the molecular immunological characteristics of lesions in patients with halo nevi when compared to stable vitiligo, normal nevocytic nevi and cutaneous melanoma［J］. J Inflamm Res, 2021,14:4111⁃4124. doi: 10.2147/JIR.S321672.
［11］	Kumar Jha A, Sonthalia S, Lallas A, et al. Dermoscopy in vitiligo: diagnosis and beyond［J］. Int J Dermatol, 2018,57（1）:50⁃54. doi: 10.1111/ijd.13795.
［12］	Gupta P, Vinay K, Bishnoi A, et al. A prospective observational study to sequentially determine the dermoscopic features of vitiligo and its association with disease activity in patients on medical treatment: dermoscopy and disease activity in vitiligo［J］. Pigment Cell Melanoma Res, 2023,36（1）:33⁃41. doi: 10. 1111/pcmr.13069.
［13］	胡文婷, 许爱娥. 晕痣的研究进展［J］. 中国皮肤性病学杂志,2017,31（7）:800⁃802. doi: 10.13735/j.cjdv.1001⁃7089.201607001.
［14］	金城, 陆洪光, 赵志国, 等. 晕痣的免疫组化特点与自发性消退机制的研究［J］. 中华皮肤科杂志, 2008,41（4）:237⁃240.doi:10.3321/j.issn:0412⁃4030.2008.04.009
［15］	George EV, Kalen JE, Kapil JP, et al. Comparison of the inflammatory infiltrates in tumoral melanosis, regressing nevi, and regressing melanoma［J］. Am J Dermatopathol, 2019,41（7）:480⁃487. doi: 10.1097/DAD.0000000000001346.
［16］	Park HS, Jin SA, Choi YD, et al. Foxp3（+） regulatory T cells are increased in the early stages of halo nevi: clinicopathological features of 30 halo nevi［J］. Dermatology, 2012,225（2）:172⁃178. doi: 10.1159/000342757.
［17］	Kano S, Nakamura M, Nojiri Y, et al. Differences in the immune microenvironment between improved and non⁃improved cases of vitiligo after halo nevus excision［J］. J Dermatol Sci, 2023,109（3）:136⁃142. doi: 10.1016/j.jdermsci.2023.03.004.
［18］	Yang Y, Li S, Zhu G, et al. A similar local immune and oxidative stress phenotype in vitiligo and halo nevus［J］. J Dermatol Sci, 2017,87（1）:50⁃59. doi: 10.1016/j.jdermsci.2017.03.008.
［19］	Lin F, Hu W, Xu W, et al. CXCL9 as a key biomarker of vitiligo activity and prediction of the success of cultured melanocyte transplantation［J］. Sci Rep, 2021,11（1）:18298. doi: 10.1038/s41598⁃021⁃97296⁃2.
［20］	Lorentzen HF. Eruptive halo naevi: a possible indicator of malignant disease in a case series of post⁃adolescent patients［J］. Acta Derm Venereol, 2020,100（15）:adv00228. doi: 10.2340/ 00015555⁃3568.
［21］	Emre S, Süngü N, Hayran Y, et al. Investigation of the PD⁃1/PD⁃L1 expression in the lesional skins of patients with psoriasis［J］. Dermatol Pract Concept, 2023,13（2）:e2023134. doi: 10.5826/ dpc.1302a134.
［22］	Tan CL, Kuchroo JR, Sage PT, et al. PD⁃1 restraint of regulatory T cell suppressive activity is critical for immune tolerance［J］. J Exp Med, 2021,218（1）:e20182232. doi: 10.1084/jem.20182232.
［23］	曹伟, 冯玉婷, 王小媛, 等. 寻常型白癜风与晕痣患者外周血T淋巴细胞亚群及Th1/Th2、Th17/Treg细胞平衡比较［J］. 实用临床医药杂志, 2020,24（12）:84⁃86. doi: 10.7619/jcmp.2020 12024.
［24］	Halliday GM, Patel A, Hunt MJ, et al. Spontaneous regression of human melanoma/nonmelanoma skin cancer: association with infiltrating CD4+ T cells［J］. World J Surg, 1995,19（3）:352⁃358. doi: 10.1007/BF00299157.
［25］	Schiferle EB, Cheon SY, Ham S, et al. Rejection of benign melanocytic nevi by nevus⁃resident CD4（+） T cells［J］. Sci Adv, 2021,7（26）:eabg4498. doi: 10.1126/sciadv.abg4498.
［26］	Fernández⁃Herrera J, Fernández⁃Ruiz E, López⁃Cabrera M, et al. CD69 expression and tumour necrosis factor⁃alpha immunoreactivity in the inflammatory cell infiltrate of halo naevi［J］. Br J Dermatol, 1996,134（3）:388⁃393.
［27］	Farinazzo E, Zelin E, Agozzino M, et al. Regression of nevi, vitiligo⁃like depigmentation and halo phenomenon may indicate response to immunotherapy and targeted therapy in melanoma［J］. Melanoma Res, 2021,31（6）:582⁃585. doi: 10.1097/CMR.000 0000000000776.
［28］	Ding GZ, Zhao WE, Li X, et al. A comparative study of mitochondrial ultrastructure in melanocytes from perilesional vitiligo skin and perilesional halo nevi skin［J］. Arch Dermatol Res, 2015,307（3）:281⁃289. doi: 10.1007/s00403⁃015⁃1544⁃4.
［29］	Beyer AM, Norwood Toro LE, Hughes WE, et al. Autophagy, TERT, and mitochondrial dysfunction in hyperoxia［J］. Am J Physiol Heart Circ Physiol, 2021,321（5）:H985⁃H1003. doi: 10. 1152/ajpheart.00166.2021.
［30］	Varga G, Gattorno M, Foell D, et al. Redox distress and genetic defects conspire in systemic autoinflammatory diseases［J］. Nat Rev Rheumatol, 2015,11（11）:670⁃680. doi: 10.1038/nrrheum. 2015.105.
［31］	Seneschal J, Boniface K, D′Arino A, et al. An update on Vitiligo pathogenesis［J］. Pigment Cell Melanoma Res, 2021,34（2）:236⁃243. doi: 10.1111/pcmr.12949.
［32］	胡文婷, 黄骏, 许爱娥. 不同治疗方法对晕痣疗效的影响因素分析［J］. 中华皮肤科杂志, 2018,51（2）:121⁃125. doi: 10.3760/cma.j.issn.0412⁃4030.2018.02.008.
［33］	Wang K, Wang Z, Huang W. Resolution of vitiligo following excision of halo congenital melanocytic nevus: a rare case report［J］. Dermatol Ther, 2016,29（3）:145⁃147. doi: 10.1111/dth.12326.
［34］	Hu WT, Lin FQ, Xu AE. Treatment of halo naevus with the topical Janus kinase inhibitor tofacitinib 1.5［J］. Clin Exp Dermatol, 2018,43（8）:935⁃937. doi: 10.1111/ced.13672.
［35］	Abdel Aziz RTA, Awad SS, Mohammed SS. Effectiveness and safety of Chinese cups in the treatment of halo nevi［J］. Dermatol Surg, 2021,47（1）:150⁃151. doi: 10.1097/DSS.0000000000002288.

[1]	Dai Yeqin, Song Xiuzu. Application of hair follicle transplantation and follicular cell suspension transplantation in the treatment of vitiligo [J]. Chinese Journal of Dermatology, 2024, 0(3): 20230274-e0230274.
[2]	Zong Yangyongyi, Ma Chujun, Su Zhonglan. Eczematization following the treatment of psoriasis with biological agents: pathogenesis and management [J]. Chinese Journal of Dermatology, 2024, 0(3): 20220578-e20220578.
[3]	Hospital for Skin Diseases, Chinese Academy of Medical Sciences, National Center for STD Control, Chinese Center for Disease Control and Prevention, Venereology Group, Chinese Society of Dermatology, Chinese Association Rehabilitation of Dermatology . Chinese expert consensus on the diagnosis and treatment of Mycoplasma genitalium infection （2024） [J]. Chinese Journal of Dermatology, 2024, 57(3): 201-208.
[4]	Lu Qin, Huang Meirong, Yang Hui, Zhang Ningqing, Min Xun, Huang Jian, . Preliminary evaluation of the immunoprotective effect of MetQ, a Neisseria gonorrhoeae vaccine candidate protein for intranasal immunization [J]. Chinese Journal of Dermatology, 2024, 57(3): 233-239.
[5]	Wang Qianqiu, Zheng Xiaoli, Du Fangzhi, Zhang Xu. Stop syphilis transmission: new situation and new strategies [J]. Chinese Journal of Dermatology, 2024, 57(3): 209-212.
[6]	Chinese Society of Dermatology, National Center for STD Control, Chinese Center for Disease Control and Prevention, China Dermatologist Association, Chinese Association Rehabilitation of Dermatology. Guideline for the diagnosis and treatment of Chlamydia trachomatis urogenital infection in China （2024） [J]. Chinese Journal of Dermatology, 2024, 57(3): 193-200.
[7]	Ge Xinhong, Ma Yingdong, Jiao Yaning, Liu Lingling, Zhou Mei, Zi Wei, Li Bowen. Analysis of efficacy and safety of 532-nm picosecond laser in the treatment of early-stage facial seborrheic keratosis [J]. Chinese Journal of Dermatology, 2024, 0(2): 20230061-e20230061.
[8]	China Dermatologist Association, Chinese Society of Dermatology, Dermatology Branch of China International Exchange and Promotive Association for Medical and Health Care, State Key Laboratory of Complex Severe and Rare Diseases, National Clinical Research Center for Dermatologic and Immunologic Diseases. Expert consensus on the application and management of therapeutic drugs for atopic dermatitis （2024） [J]. Chinese Journal of Dermatology, 2024, 57(2): 97-108.
[9]	Na Jun, Li Ruoyu, Zhong Shaomin, Yang Li, Wu Yan. Diagnosis and treatment of rosacea in the real world: a survey on the current status [J]. Chinese Journal of Dermatology, 2024, 57(2): 127-133.
[10]	Sun Weiwei, Chen Jianru, Li Shuli, Gao Tianwen, Li Chunying . Analysis of depression-like behavioral performances of mouse models of vitiligo [J]. Chinese Journal of Dermatology, 2024, 57(2): 147-154.
[11]	Wang Tao, Wu Yi, Jin Hong, Dai Yeqin, Peng Jianzhong, Xu Ai′e, Song Xiuzu. Efficacy of electrolysis of depigmented hair combined with hair follicle transplantation in the treatment of 25 cases of vitiligo-associated leukotrichia: a retrospective analysis [J]. Chinese Journal of Dermatology, 2024, 57(1): 46-49.
[12]	Skin Cancer Research Group, Committee on Dermatology, Chinese Association of Integrative Medicine, Melanoma Society of China Anti-Cancer Association. Expert consensus on human interferon α1b for the treatment of melanoma （2024） [J]. Chinese Journal of Dermatology, 2024, 57(1): 1-7.
[13]	Guliziba·Tuersun, Qu Yuanyuan. New advances in the treatment of vitiligo with JAK-STAT inhibitors [J]. Chinese Journal of Dermatology, 2024, 57(1): 71-75.
[14]	Chen Hui, Li Bing, Li Chunying, Guo Weinan . Comparison of the efficacy of water jet-assisted dermabrasion versus electric dermabrasion in combination with suction blister epidermal grafting in the treatment of vitiligo [J]. Chinese Journal of Dermatology, 2024, 57(1): 43-45.
[15]	He Kaiqiao, Li Shuli, Li Baizhang, Liu Ling, Li Chunying. Clinical observation of repigmentation patterns in patients with vitiligo treated with phototherapy and analysis of their influencing factors [J]. Chinese Journal of Dermatology, 2024, 57(1): 23-28.

Research progress in halo nevi

PDF

PDF (Mobile)

Knowledge

Abstract

Cite this article

share this article

References ［35］

Related Articles 15

Metrics

Comments

Recommended 10